Zyn Submits Modified Risk Applications for Nicotine Pouches
The FDA will now review whether 20 Zyn nicotine pouch products "[put] you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis,” as the company claims.